Global Peptide Cancer Vaccine Market Research Report 2018

Publisher Name :
Date: 04-Dec-2018
No. of pages: 184
Inquire Before Buying

This report studies the Peptide Cancer Vaccine market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Peptide Cancer Vaccine market by product type and applications/end industries.

The major players in global Peptide Cancer Vaccine market include

TapImmune

BrightPath Biotherapeutics

Ultimovacs

Sellas

Boston Biomedical

Imugene

VAXON Biotech

Generex Biotechnology

ISA Pharmaceuticals

OncoTherapy Science

Immatics

Geographically, this report is segmented into several key Regions, with market size, market share and growth rate of Peptide Cancer Vaccine in these regions, from 2020 to 2030 (forecast), covering

USA

Europe

China

Japan

South America

RoW

On the basis on the end users/applications, this report covers

Breast Cancer

Lung Cancer

Melanoma

Prostate Cancer

Others

Global Peptide Cancer Vaccine Market Research Report 2018

Table of Contents
1 Peptide Cancer Vaccine Market Overview 1
1.1 Peptide Cancer Vaccine Product Overview 1
1.2 Peptide Vaccine Strategies in the Treatment of Cancer 1
1.3 Global Peptide Cancer Vaccine Segment by Applications 4
1.3.1 Global Peptide Cancer Vaccine Revenue Market Share by Applications in 2025 4
1.3.2 Breast Cancer 4
1.3.3 Lung Cancer 5
1.3.4 Melanoma 6
1.3.5 Prostate Cancer 7
1.4 Global Peptide Cancer Vaccine Market by Regions (2020-2030) 8
1.4.1 Global Peptide Cancer Vaccine Market Size and Growth Rate Comparison by Regions (2020-2030) 8
1.4.2 USA Peptide Cancer Vaccine Status and Prospect (2020-2030) 9
1.4.3 Europe Peptide Cancer Vaccine Status and Prospect (2020-2030) 10
1.4.4 Japan Peptide Cancer Vaccine Status and Prospect (2020-2030) 11
1.4.5 China Peptide Cancer Vaccine Status and Prospect (2020-2030) 12
1.4.6 South America Peptide Cancer Vaccine Status and Prospect (2020-2030) 13
1.5 Global Peptide Cancer Vaccine Market Size (2020-2030) 14
1.6 Global Manufacturers Peptide Cancer Vaccine Headquarters, Established Date and Product 14
2 Cancer Vaccines and Immunotherapy 16
2.1 Therapeutic Vaccines 16
2.1.1 Autologous Cancer Vaccines 17
2.1.2 Allogenic Cancer Vaccines 18
2.1.3 Protein or Peptide Cancer Vaccines 18
2.1.4 DNA Vaccines 18
2.2 Other Approaches 18
2.3 Clinical Considerations for Therapeutic Cancer Vaccines 19
2.3.1 Considerations for both Early and Late Phase Clinical Trials 20
2.3.2 Considerations for Early Phase Clinical Trials 20
2.3.3 Considerations for Late Phase Clinical Trials 21
3 Wide Spectrum Action of Peptide Cancer Vaccines against Major Cancer 22
3.1 Peptides & Colorectal Cancer 22
3.1.1 Colorectal Cancer Introduction 22
3.1.2 Introduction of the Number of Patients with Colorectal Cancer 22
3.1.3 Peptide Cancer Vaccine Introduction about Colorectal Cancer 23
3.2 Peptides & Lung Cancer 24
3.2.1 Lung Cancer Introduction 24
3.2.2 Introduction of the Number of Patients with Lung Cancer 25
3.2.3 Peptide Cancer Vaccine Introduction about Lung Cancer 27
3.3 Peptides & Pancreatic Cancer 28
3.3.1 Pancreatic Cancer Introduction 28
3.3.2 Introduction of the Number of Patients with Pancreatic Cancer 29
3.3.3 Peptide Cancer Vaccine Introduction about Pancreatic Cancer 30
3.4 Peptides & Breast Cancer 31
3.4.1 Breast Cancer Introduction 31
3.4.2 Introduction of the Number of Patients with Breast Cancer 31
3.4.3 Peptide Cancer Vaccine Introduction about Breast Cancer 32
3.5 Peptides & Prostate Cancer 33
3.5.1 Prostate Cancer Introduction 33
3.5.2 Introduction of the Number of Patients with Prostate Cancer 34
3.5.3 Peptide Cancer Vaccine Introduction about Prostate Cancer 35
3.6 Peptides & Other Cancer 36
4 Global Peptide Cancer Vaccine by Pipeline 39
4.1 ITK-1 39
4.2 GRN-1201 40
4.3 TPIV200 42
4.4 TPIV110 42
4.5 UV1 43
4.6 galinpepimut-S 44
4.7 TARP 27-35 44
4.8 HER-Vaxx 45
4.9 Vx-001 47
4.10 Vx-006 48
4.11 Vx-016 48
4.12 AE37 49
4.13 ISA101 (HPV) 51
4.14 MyISA (Personalized immunotherapy based on neoantigens) 52
4.15 ISA203 (PRAME) 53
4.16 ISA204 (HBV) 53
4.17 OTSA101 54
4.18 GALINPEPIMUT-S AND KEYTRUDA (PEMBROLIZUMAB) 55
4.19 ACTolog 56
4.20 DSP-7888 Dosing Emulsion plus Bevacizumab 57
4.21 DSP-7888 in Patients with Myelodysplastic Syndrome (MDS) 57
4.22 DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas 58
4.23 DSP-7888 Dosing Emulsion in Adult Patients with Advanced Malignancies 58
5 Global Cancer Vaccine Consumption by Regions (2013-2018) 59
5.1 Global Cancer Vaccine Consumption by Regions (2013-2018) 59
5.2 North America Cancer Vaccine Consumption (2013-2018) 63
5.3 Europe Cancer Vaccine Consumption (2013-2018) 65
5.4 China Cancer Vaccine Consumption (2013-2018) 67
5.5 Japan Cancer Vaccine Consumption (2013-2018) 69
6 Cancer Vaccine Market Size Analysis by Main Players 2013-2018 71
6.1 Global Cancer Vaccine Sales and Share by Manufacturers (2013-2018) 71
6.2 Global Cancer Vaccine Revenue and Share by Manufacturers (2013-2018) 73
6.3 Vaccine Market Size Analysis by Main Players 74
6.3.1 Merck 74
6.3.2 GSK 79
6.3.3 Dendreon 82
7 Analysis of Peptide Cancer Vaccine Industry Key Manufacturers 86
7.1 Boston Biomedical 86
7.1.1 Company Profile 86
7.1.2 Product Information 87
7.2 Ultimovacs 87
7.2.1 Company Profile 87
7.2.2 Product Information 88
7.3 BrightPath Biotherapeutics 90
7.3.1 Company Profile 90
7.3.2 Product Information 92
7.4 TapImmune 94
7.4.1 Company Profile 94
7.4.2 Product Information 96
7.5 Immatics 97
7.5.1 Company Profile 97
7.5.2 Product Information 98
7.6 Sellas 99
7.6.1 Company Profile 99
7.6.2 Product Information 100
7.7 Imugene 101
7.7.1 Company Profile 101
7.7.2 Product Information 102
7.8 VAXON Biotech 102
7.8.1 Company Profile 102
7.8.2 Product Information 104
7.9 Generex Biotechnology 104
7.9.1 Company Profile 104
7.9.2 Product Information 106
7.10 ISA Pharmaceuticals 106
7.10.1 Company Profile 106
7.10.2 Product Information 107
7.11 OncoTherapy Science 108
7.11.1 Company Profile 108
7.11.2 Product Information 110
8 Peptide Cancer Vaccine Manufacturing Cost Analysis 112
8.1 Peptide Cancer Vaccine R&D Cost Analysis 112
8.1.1 Clinical Phase Costs 113
8.1.2 Capitalized Costs 114
8.2 Proportion of Manufacturing Cost Structure 115
8.2.1 Raw Materials 115
8.2.2 Labor Cost 116
8.2.3 Other Costs Analysis 122
8.3 Manufacturing Process Analysis of Peptide Cancer Vaccine 127
9 Industrial Chain, Sourcing Strategy and Downstream Buyers 130
9.1 Peptide Cancer Vaccine Peptide Cancer Vaccine Discovery and Development Analysis 130
9.2 Upstream Raw Materials Sourcing 131
9.3 Downstream Buyers 132
10 Marketing Strategy Analysis 134
10.1 Marketing Channel 134
10.1.1 Direct Marketing 134
10.1.2 Indirect Marketing 134
10.1.3 Marketing Channel Development Trend 134
10.2 Market Positioning 135
10.2.1 Pricing Strategy 135
10.2.2 Brand Strategy 137
11 Market Effect Factors Analysis 139
11.1 Technology Progress in Related Industry 139
11.2 Consumer Needs/Customer Preference Change 140
11.3 Economic/Political Environmental Change 141
12 Global Peptide Cancer Vaccine Market Forecast (2020-2030) 151
12.1 Global Peptide Cancer Vaccine Revenue Forecast (2020-2030) 151
12.2 Global Peptide Cancer Vaccine Revenue Forecast by Regions (2020-2030) 151
12.3 Global Peptide Cancer Vaccine Consumption Forecast by Regions (2020-2030) 154
12.3.1 USA Peptide Cancer Vaccine Consumption Forecast (2020-2030) 157
12.3.2 Europe Peptide Cancer Vaccine Consumption Forecast (2020-2030) 158
12.3.3 China Peptide Cancer Vaccine Consumption Forecast (2020-2030) 159
12.3.4 Japan Peptide Cancer Vaccine Consumption Forecast (2020-2030) 160
12.3.5 South America Peptide Cancer Vaccine Consumption Forecast (2020-2030) 161
12.4 Global Peptide Cancer Vaccine Consumption Forecast by Application (2020-2030) 161
13 Research Findings and Conclusion 164
14 Methodology and Data Source 165
14.1 Methodology/Research Approach 165
14.1.1 Research Programs/Design 165
14.1.2 Market Size Estimation 166
14.1.3 Market Breakdown and Data Triangulation 167
14.2 Data Source 168
14.2.1 Secondary Sources 168
14.2.2 Primary Sources 169
14.3 Disclaimer 170
14.4 Author List 172
List of Tables and Figures
Figure Product Picture of Peptide Cancer Vaccine 1
Figure Global Peptide Cancer Vaccine Revenue Market Share by Applications in 2025 4
Figure Breast Cancer Examples 5
Figure Lung Cancer Examples 6
Figure Melanoma Examples 7
Figure Prostate Cancer Examples 7
Table Peptide Cancer Vaccine Market Size (M USD) Comparison by Regions (2020-2030) 8
Figure USA Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030) 9
Figure Europe Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030) 10
Figure Japan Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030) 11
Figure China Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030) 12
Figure South America Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030) 13
Figure Global Peptide Cancer Vaccine Revenue (M USD) Status and Outlook (2020-2030) 14
Table Global Players/Manufacturers Peptide Cancer Vaccine Headquarters and Established Date 14
Table Global Manufacturers Peptide Cancer Vaccine Product 15
Top 20 Countries Highest Incidence of Colorectal Cancer in 2016 23
Top 20 Countries Highest Incidence of Lung Cancer in 2016 25
Figure Percent of New Cases by Age Group: Lung Cancer 26
Figure Percent of Deaths by Age Group: Lung Cancer 26
Table Active Immunotherapies in Phase III Development 27
Top 20 Countries Highest Incidence of Pancreatic Cancer in 2016 29
Table Active Immunotherapies in Phase III Development 30
Top 20 Countries Highest Incidence of Breast Cancer in 2016 32
Table Active Immunotherapies in Phase III Development 33
Figure Percent of New Cases by Age Group: Prostate Cancer 34
Figure Percent of Deaths by Age Group: Prostate Cancer 35
Figure Estimated Prostate Cancer Incidence Worldwide in 2016 35
Information about World Cancer Statistics for the Most Common Cancers (excluding non-melanoma Skin Cancer) in 2016 37
Table Active Immunotherapies in Phase III Development 37
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 39
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 40
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 41
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 41
Figure UV1 Technology 43
Figure How HER-Vaxx is Tntended to Work 47
Figure Molecular Modeling Study-MHC Class II Receptor 50
Figure Li Suppression 50
Figure Li-KEY Hybrid 51
Figure Antitumor Activity of OTSA101 55
Figure Peptide Cancer Vaccine Product Information of Sellas 55
Figure Peptide Cancer Vaccine Product Information of Immatics 56
Figure Peptide Cancer Vaccine Product Information of Boston Biomedical 57
Figure Peptide Cancer Vaccine Product Information of Sumitomo Dainippon 57
Figure Peptide Cancer Vaccine Product Information of Sumitomo Dainippon 58
Figure Peptide Cancer Vaccine Product Information of Boston Biomedical 58
Table Global Cancer Vaccine Consumption (K Doses) Market by Regions (2013-2018) 59
Table Global Cancer Vaccine Consumption Market Share by Regions (2013-2018) 59
Figure Global Cancer Vaccine Consumption Market Share by Regions (2013-2018) 60
Figure 2017 Global Cancer Vaccine Consumption Market Share by Regions 60
Table Global Cancer Vaccine Revenue (M USD) Market by Regions (2013-2018) 61
Table Global Cancer Vaccine Revenue Market Share by Regions (2013-2018) 61
Figure Global Cancer Vaccine Revenue Market Share by Regions (2013-2018) 61
Figure 2017 Global Cancer Vaccine Revenue Market Share by Regions 62
Figure North America Cancer Vaccine Consumption (K Doses) and Growth Rate (2013-2018) 63
Figure North America Cancer Vaccine Revenue (M USD) and Growth Rate (2013-2018) 64
Figure Europe Cancer Vaccine Consumption (K Doses) and Growth Rate (2013-2018) 65
Figure Europe Cancer Vaccine Revenue (M USD) and Growth Rate (2013-2018) 66
Figure China Cancer Vaccine Consumption (K Doses) and Growth Rate (2013-2018) 67
Figure China Cancer Vaccine Revenue (M USD) and Growth Rate (2013-2018) 68
Figure Japan Cancer Vaccine Consumption (K Doses) and Growth Rate (2013-2018) 69
Figure Japan Cancer Vaccine Revenue (M USD) and Growth Rate (2013-2018) 70
Table Global Cancer Vaccine Sales (K Doses) of Key Manufacturers (2013-2018) 71
Table Global Cancer Vaccine Sales Market Share by Manufacturers (2013-2018) 71
Figure 2013 Cancer Vaccine Sales Market Share by Manufacturers 72
Figure 2017 Cancer Vaccine Sales Market Share by Manufacturers 72
Table Global Cancer Vaccine Revenue (M USD) by Manufacturers (2013-2018) 73
Table Global Cancer Vaccine Revenue Share by Manufacturers (2013-2018) 73
Figure 2013 Global Cancer Vaccine Revenue Share by Manufacturers 73
Figure 2017 Global Cancer Vaccine Revenue Share by Manufacturers 74
Table Merck Company Profile 74
Table Cancer Vaccine Product Information of Merck 76
Table Cancer Vaccine Sales (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck 2013-2018 77
Figure Cancer Vaccine Sales (K Doses) and Growth Rate of Merck 2013-2018 78
Figure Cancer Vaccine Revenue (M USD) and Global Market Share of Merck 2013-2018 79
Table GSK Company Profile 79
Table Cancer Vaccine Product Information of GSK 80
Table Cancer Vaccine Sales (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GSK 2013-2018 81
Figure Cancer Vaccine Sales (K Doses) and Growth Rate of GSK 2013-2018 81
Figure Cancer Vaccine Revenue (M USD) and Global Market Share of GSK 2013-2018 82
Table Dendreon Company Profile 82
Table Cancer Vaccine Product Information of Dendreon 83
Table Cancer Vaccine Sales (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dendreon 2013-2018 84
Figure Cancer Vaccine Sales (K Doses) and Growth Rate of Dendreon 2013-2018 84
Figure Cancer Vaccine Revenue (M USD) and Global Market Share of Dendreon 2013-2018 85
Table Boston Biomedical Company Profile 86
Figure Peptide Cancer Vaccine Product Information of Boston Biomedical 87
Table Ultimovacs Company Profile 87
Table Peptide Cancer Vaccine Product Picture and Specifications of Ultimovacs 88
Table BrightPath Biotherapeutics Company Profile 90
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 92
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 93
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 94
Table TapImmune Company Profile 94
Figure Peptide Cancer Vaccine Product Picture and Specifications of TapImmune 96
Table Immatics Company Profile 97
Figure Peptide Cancer Vaccine Product Information of Immatics 98
Table Sellas Company Profile 99
Figure Peptide Cancer Vaccine Product Information of Sellas 100
Table Imugene Company Profile 101
Figure Peptide Cancer Vaccine Product Picture of Imugene 102
Table VAXON Biotech Company Profile 102
Figure Peptide Cancer Vaccine Product Picture of VAXON Biotech 104
Table Generex Biotechnology Company Profile 104
Figure Peptide Cancer Vaccine Product Picture of Generex Biotechnology 106
Table ISA Pharmaceuticals Company Profile 106
Table OncoTherapy Science Company Profile 108
Figure Peptide Cancer Vaccine Product Picture of OncoTherapy Science 110
Figure Typical Phases from Research to the Market for a Cancer Vaccine Candidate 113
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound 114
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 115
Figure Manufacturing Cost Structure of Peptide Cancer Vaccine 115
Figure USA Overview of Average Hourly Wages 2015-2016 (USD/Hour) 116
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points) 117
Figure Cost of Employing a Factory Worker 118
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe 119
Figure Monthly Minimum Wages in Asia 2016 120
Figure China Overview of Average Yearly Wages 2016-2017 (CNY/Year) 121
Figure Japan Overview of Average Monthly Wages 2016-2017 (JPY Thousand/Month) 121
Table Average Price of Electricity to Ultimate Customers 122
Figure Electricity Prices for Household Consumers in 2016 123
Figure Summary of the Driving Assumptions 124
Figure Industrial Electric Rates 2016 (PER KWH) 125
Figure Anti-cancer Process 127
Figure Manufacturing Process Analysis of Peptide Cancer Vaccine 128
Figure Roadmap to the Development of Predictive Biomarkers for Active Immunotherapy 129
Figure Peptide Cancer Vaccine Discovery and Development 130
Table Major Buyers of Peptide Cancer Vaccine 132
Figure Setting Pricing Policy 136
Figure Global GDP Growth Rate for 2016 142
Figure Real GDP Growth 2016-2020 annual Average 143
Figure US GDP 2006-2016 (Billion USD) 144
Figure US CPI Change 2016-2017 144
Figure EU GDP 2006-2016 (Billion USD) 145
Figure EU CPI Change 2012-2016 145
Figure Germany GDP 2006-2016 (Billion USD) 146
Figure Germany CPI Change 2016-2017 146
Figure UK GDP 2006-2016 (Billion USD) 147
Figure UK CPI Change 2016-2017 147
Figure Italy GDP 2006-2016 (Billion USD) 148
Figure Italy CPI Change 2016-2017 148
Figure Japan GDP 2006-2016 (Billion USD) 149
Figure Japan CPI Change 2012-2016 149
Figure China GDP 2006-2016 (Billion USD) 150
Figure China CPI Change 2016-2017 150
Figure Global Peptide Cancer Vaccine Revenue (M USD) and Growth Rate Forecast (2020-2030) 151
Table Global Peptide Cancer Vaccine Revenue (M USD) Forecast by Regions (2020-2025) 151
Table Global Peptide Cancer Vaccine Revenue (M USD) Forecast by Regions (2025-2030) 152
Table Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions (2020-2025) 152
Table Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions (2025-2030) 152
Figure Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions (2020-2030) 153
Figure Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions in 2025 153
Table Global Peptide Cancer Vaccine Consumption (M USD) Forecast by Regions (2020-2025) 154
Table Global Peptide Cancer Vaccine Consumption (M USD) Forecast by Regions (2025-2030) 154
Table Global Peptide Cancer Vaccine Consumption Market Share Forecast by Regions (2020-2025) 154
Table Global Peptide Cancer Vaccine Consumption Market Share Forecast by Regions (2025-2030) 155
Figure Global Peptide Cancer Vaccine Consumption Market Share Forecast by Regions (2020-2030) 155
Figure Global Peptide Cancer Vaccine Consumption Market Share Forecast by Regions in 2025 156
Figure USA Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030) 157
Figure Europe Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030) 158
Figure China Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030) 159
Figure Japan Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030) 160
Figure South America Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030) 161
Table Global Peptide Cancer Vaccine Consumption (M USD) Forecast by Application (2020-2025) 161
Table Global Peptide Cancer Vaccine Consumption (M USD) Forecast by Application (2025-2030) 162
Table Global Peptide Cancer Vaccine Consumption Forecast by Application (2020-2025) 162
Table Global Peptide Cancer Vaccine Consumption Forecast by Application (2025-2030) 162
Figure Global Peptide Cancer Vaccine Consumption Forecast by Application (2020-2030) 163
Figure Global Peptide Cancer Vaccine Consumption Forecast by Application in 2025 163
Table Research Programs/Design for This Report 165
Figure Bottom-up and Top-down Approaches for This Report 167
Figure Data Triangulation 168
Table Key Data Information from Secondary Sources 169
Table Key Data Information from Primary Sources 170
  • Global Peptide Cancer Vaccine Market Growth 2019-2024
    Published: 20-Feb-2019        Price: US 3660 Onwards        Pages: 166
    Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host. Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The unde......
  • Global BCG Vaccine Market Insights, Forecast to 2025
    Published: 15-Feb-2019        Price: US 3900 Onwards        Pages: 110
    BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme. The global average gross margin of BCG Vaccine i......
  • Global Cancer Vaccines Drug Pipeline Industry Market Research 2019
    Published: 15-Feb-2019        Price: US 2600 Onwards        Pages: 162
    In this report, we analyze the Cancer Vaccines Drug Pipeline industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We ......
  • Global Peptide Cancer Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 13-Feb-2019        Price: US 3480 Onwards        Pages: 119
    Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host. Scope of the Report: Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several c......
  • Global BCG Vaccine Market Growth 2019-2024
    Published: 11-Feb-2019        Price: US 3660 Onwards        Pages: 137
    BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme. The global average gross margin of BCG Vaccine i......
  • Global Cervical Cancer Vaccine Market Insights, Forecast to 2025
    Published: 08-Feb-2019        Price: US 3900 Onwards        Pages: 114
    The global Cervical Cancer Vaccine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cervical Cancer Vaccine market based on company, product type, end user and key regions. This report studies the global market size of Cervical Cancer Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and......
  • Global Cancer Vaccine Market Insights, Forecast to 2025
    Published: 08-Feb-2019        Price: US 3900 Onwards        Pages: 114
    The global Cancer Vaccine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cancer Vaccine market based on company, product type, end user and key regions. This report studies the global market size of Cancer Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focu......
  • Global BCG Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 03-Feb-2019        Price: US 3480 Onwards        Pages: 120
    BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme. Scope of the Report: The global a......
  • Global Cancer Vaccine Market Research Report 2019
    Published: 28-Jan-2019        Price: US 2900 Onwards        Pages: 97
    The global Cancer Vaccine market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs